Viavi (VIAV) Insider Sale: 11,873 Shares Sold Under 10b5-1 Plan

Rhea-AI Filing Summary

Luke M. Scrivanich, SVP General Manager OSP at Viavi Solutions (VIAV), sold 11,873 shares on 08/29/2025 under a Rule 10b5-1 trading plan. The sales were executed in multiple trades at prices ranging from $11.10 to $11.27, with a reported weighted average sale price of $11.18. After the reported disposals, the reporting person beneficially owned 66,836 shares. The Form 4 indicates the transaction was made pursuant to a 10b5-1 plan dated September 11, 2024, and the filing was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Transaction executed under a Rule 10b5-1 plan, indicating a pre-established trading arrangement and compliance with insider-trading procedures
• Full disclosure of weighted average sale price range ($11.10 to $11.27) and number of shares sold (11,873) provides transparency

Negative

• Insider disposed of 11,873 shares, reducing beneficial ownership to 66,836 shares
• Sale represents a notable reduction in the reporting person's stake (explicit remaining holdings shown)

Insights

Corporate Governance Expert

TL;DR: Insider sale executed under an established 10b5-1 plan reduces governance concerns but lowers the officer's stake.

The filing documents a non-derivative sale of 11,873 common shares by an officer of Viavi Solutions pursuant to a Rule 10b5-1 plan dated September 11, 2024. Trades occurred at prices between $11.10 and $11.27, with a weighted average of $11.18, and left the reporting person with 66,836 shares. From a governance standpoint, use of a pre-established trading plan signals adherence to insider trading controls and provides affirmative defense protections. The transaction itself is routine and disclosed timely via Form 4.

Securities Analyst

TL;DR: The sale is material to the insider but not necessarily materially informative about company fundamentals.

This Form 4 shows an officer-initiated disposal executed under a documented 10b5-1 program, reporting both the number of shares sold and remaining beneficial ownership. The weighted average sale price is explicitly reported and the filing provides that trade details can be furnished on request. The disclosure is clear and complies with Section 16 reporting requirements; it does not include derivative activity or other compensatory transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCRIVANICH LUKE M

(Last) (First) (Middle)

C/O VIAVI SOLUTIONS INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

CHANDLER AZ 85286

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP General Manager OSP

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		S(1)		11,873	D	$11.18(2)	66,836	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were sold pursuant to a Rule 10b5-1 Stock Trading Plan dated September 11, 2024.

2. This transaction was executed in multiple trades at prices ranging from $11.10 to $11.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Donna T. Rossi, attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for VIAV report?

The Form 4 reports that Luke M. Scrivanich sold 11,873 shares of Viavi Solutions on 08/29/2025 under a Rule 10b5-1 plan.

At what prices were the VIAV shares sold?

Trades were executed between $11.10 and $11.27, with a reported weighted average sale price of $11.18.

How many VIAV shares does the reporting person own after the sale?

The reporting person beneficially owned 66,836 shares following the reported transaction.

Was the sale part of a trading plan?

Yes. The shares were sold pursuant to a Rule 10b5-1 trading plan dated September 11, 2024, as stated in the Form 4.

Who signed the Form 4 filing?

The Form 4 was signed by Donna T. Rossi, attorney-in-fact, on 09/02/2025 as indicated on the filing.